Related Experiment Video
Updated: Jun 5, 2026
Acellular and Cellular Lung Model to Study Tumor Metastasis
Published on: August 19, 2018
Cellular therapies for lung disease: a distant horizon
Yuben Moodley1, Ursula Manuelpillai, Daniel J Weiss
1School of Medicine and Pharmacology, University of Western Australia, Royal Perth Hospital, Perth, Western Australia, Australia. yuben.moodley@uwa.edu.au
Abstract:
Lung diseases constitute a major global burden of health and are characterized by inflammation and chronic fibrosis resulting in a loss of gas exchange units. To date there has been no effective treatment to reverse these chronic inflammatory changes and tissue remodelling. Recently, stem cells have been shown to successfully treat animal models of lung disease. In addition, certain cells have demonstrated a capacity to differentiate into lung cells. Based on these preliminary data, there are clinical trials underway to examine the potential for cellular therapies in lung disease. Recently, there have been a variety of cell examined for both their immunomodulatory effects on the lung as well as their potential for differentiation into lung cells. These range from lung progenitor cells, circulating cells, mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPS), placental stem cells and embryonic stem cells (ESCs). Several cell types demonstrate immunomodulatory effects including circulating cells, MSCs and placental stem cells. In addition, iPS, placental cells and ESCs have shown some capacity for differentiation. Despite these major steps forward cellular therapy for lung diseases still faces challenges. Issues that need to be resolved include bioethical issues, the safety of cell transplantation, ideal routes of delivery, the timing and the specific indications that would make cellular therapy effective.
Insights
Cellular therapies show promise for treating lung diseases by reducing inflammation and fibrosis. Ongoing research explores various stem cells, but challenges like safety and delivery methods need resolution for effective clinical application.
Area of Science:
- Regenerative Medicine
- Pulmonology
- Cell Biology
Background:
- Lung diseases cause significant global health issues, characterized by inflammation and fibrosis, leading to impaired gas exchange.
- Current treatments lack the ability to reverse chronic inflammatory changes and tissue remodeling in lung diseases.
- Stem cell research shows potential for treating lung diseases, with some cells differentiating into lung cells.
Purpose of the Study:
- To review the potential of cellular therapies for treating lung diseases.
- To examine various cell types investigated for their immunomodulatory and differentiation capacities in lung disease models.
- To identify challenges and future directions for cellular therapy in lung disease.
Main Methods:
- Review of current research on stem cell applications in lung disease models.
- Analysis of different cell types, including lung progenitor cells, circulating cells, mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPS), placental stem cells, and embryonic stem cells (ESCs).
- Evaluation of studies focusing on immunomodulatory effects and differentiation potential of these cells.
Main Results:
- Several cell types, including circulating cells, MSCs, and placental stem cells, exhibit immunomodulatory effects beneficial for lung conditions.
- Induced pluripotent stem cells (iPS), placental cells, and embryonic stem cells (ESCs) have demonstrated differentiation capacity relevant to lung tissue.
- Clinical trials are exploring the efficacy of cellular therapies for various lung diseases.
Conclusions:
- Cellular therapy offers a promising avenue for treating lung diseases, with stem cells showing potential for both immune modulation and tissue repair.
- Despite advancements, significant challenges remain, including bioethical considerations, transplantation safety, optimal delivery routes, and defining specific therapeutic indications.
- Further research and clinical trials are essential to overcome these hurdles and establish effective cellular therapies for lung diseases.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:30Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:29Microorganisms in Medicine and Therapeutics